HealthVerity Inc. acquires Curisium to improve data sharing processes

By Nikita Chaurasia  Date: 2020-07-22

HealthVerity Inc. acquires Curisium to improve data sharing processes

HealthVerity, a leader in privacy protected data exchange, has made it to the headlines on announcing the purchase of Curisium, a cloud-based drug rebate processing and contract performance management company.

According to reliable sources, the partnership will allow for development of advanced infrastructure for high-governance as well as sharing of privacy-compliant data among the pharmaceutical manufacturers, payers, and pharmacy benefits managers (PBMs).

As per the agreement, current clients of Curisium will reportedly use latest technologies that help in streamlining and developing contract negotiation, rebate validation, and invoicing process through an advanced SaaS solution.

HealthVerity CEO Andrew Kress was reported saying that Curisium possesses the vision to develop advanced SaaS platforms and other innovative solutions which enable parties to easily negotiate and visualize relationships based on contracts around drug utilization. He added that this vision is similar to the HealthVerity’s strategy of making data ecosystem available for analyzing or sharing applications.

Andrew further claimed that HealthVerity Inc. intends to integrate additional tools that offer its healthcare clients and data partners an innovative approach to transact around contracts, especially amid the rising prevalence of COVID-19.

Peter Kim Co-founder and CEO at Curisium stated that the company is looking forward to work with HealthVerity and continue its mission of supporting life science companies as well as payers with a more progressive approach to healthcare contracting. He mentioned that Curisium’s clients will now have access to clinically relevant results that have profited from these healthcare contracts, alongside improved understanding regarding the impact on patient lives.

For those uninitiated, Curisium’s platform is an operating system that is based on rules-driven and highly responsive platform. This operating system offers remotely operated standardizing payment processes, adjudication, and contracting processes. It is also capable of replacing disparate analog processes and spreadsheets.

The financial details of the deal were not disclosed.

 

Source credits-

https://www.prnewswire.com/news-releases/healthverity-acquires-curisium-to-enhance-data-exchange-for-drug-rebate-processing-and-contract-management-301095901.html?tc=eml_cleartime

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

Gan & Lee partners with IDF to expand its diabetes treatment portfolio

By Nikita Chaurasia

China-based leading pharmaceutical organization Gan & Lee Pharmaceuticals Co. Ltd. has announced to have signed a strategic collaboration with the International Diabetes Federation (IDF) to bolster its efforts towards promoting the prevention and...